REFRACTORY SOLID TUMORS
Clinical trials for REFRACTORY SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SOLID TUMORS trials appear
Sign up with your email to follow new studies for REFRACTORY SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with returning cancers: drug cocktail trial launches
Disease control Recruiting nowThis early-phase trial tests a three-drug combination (eribulin, irinotecan, and temozolomide) in children and young adults up to age 25 whose solid tumors have come back or not responded to treatment. The main goal is to find a safe dose of eribulin when given with the other two…
Matched conditions: REFRACTORY SOLID TUMORS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for kids with tough cancers: experimental drug PEEL-224 enters trials
Disease control Recruiting nowThis study tests a new drug called PEEL-224, alone or with standard chemotherapy, in children and young adults whose solid tumors have not responded to treatment or have returned. The first part finds the safest dose, and the second part measures how well the drug combination shr…
Matched conditions: REFRACTORY SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Theodore Laetsch • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Massive study aims to unlock secrets of rare cancers
Knowledge-focused Recruiting nowThis study collects biological samples and health information from up to 10,000 people with rare solid tumors or a family history of them. The goal is to learn how these tumors develop and change over time. Participants provide saliva, blood, or tumor tissue and answer yearly hea…
Matched conditions: REFRACTORY SOLID TUMORS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 05:40 UTC